Morgan Stanley’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$121K Buy
8,960
+6,742
+304% +$91.2K ﹤0.01% 6064
2025
Q1
$16.7K Buy
+2,218
New +$16.7K ﹤0.01% 6635